X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3339) 3339
Publication (189) 189
Newsletter (109) 109
Book Review (50) 50
Newspaper Article (43) 43
Book Chapter (34) 34
Magazine Article (12) 12
Dissertation (5) 5
Book / eBook (2) 2
Conference Proceeding (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
levetiracetam (3224) 3224
epilepsy (1680) 1680
humans (1576) 1576
index medicus (1424) 1424
clinical neurology (1421) 1421
piracetam - analogs & derivatives (1155) 1155
male (1089) 1089
seizures (1018) 1018
female (1015) 1015
anticonvulsants - therapeutic use (1014) 1014
antiepileptic drugs (776) 776
piracetam - therapeutic use (680) 680
adult (674) 674
neurosciences (608) 608
neurology (601) 601
anticonvulsants (558) 558
middle aged (548) 548
epilepsy - drug therapy (538) 538
anticonvulsants - adverse effects (497) 497
pharmacology & pharmacy (491) 491
animals (466) 466
treatment outcome (466) 466
double-blind (432) 432
efficacy (416) 416
adolescent (388) 388
children (383) 383
analysis (379) 379
lamotrigine (361) 361
aged (360) 360
anticonvulsants - administration & dosage (354) 354
piracetam - adverse effects (347) 347
child (344) 344
psychiatry (326) 326
status epilepticus (326) 326
drug therapy (323) 323
phenytoin (318) 318
anticonvulsants - pharmacology (306) 306
topiramate (295) 295
carbamazepine (286) 286
piracetam - administration & dosage (283) 283
dose-response relationship, drug (277) 277
pharmacokinetics (267) 267
seizures - drug therapy (266) 266
care and treatment (262) 262
piracetam - pharmacology (260) 260
pediatrics (257) 257
research (251) 251
rats (247) 247
electroencephalography (245) 245
tolerability (242) 242
drugs (241) 241
young adult (240) 240
retrospective studies (232) 232
brain (211) 211
antiepileptic drug (210) 210
drug therapy, combination (207) 207
valproic acid (194) 194
medicine & public health (185) 185
antiepileptic drug levetiracetam (179) 179
medical research (176) 176
monotherapy (176) 176
dosage and administration (174) 174
therapy (174) 174
child, preschool (170) 170
behavioral sciences (165) 165
multicenter (165) 165
valproate (165) 165
medicine, experimental (163) 163
partial seizures (162) 162
epilepsies, partial - drug therapy (161) 161
oxcarbazepine (161) 161
safety (160) 160
health aspects (153) 153
seizure (151) 151
anticonvulsants - pharmacokinetics (149) 149
etiracetam (149) 149
management (148) 148
refractory partial seizures (148) 148
disease models, animal (145) 145
partial-onset seizures (145) 145
gabapentin (144) 144
mice (140) 140
convulsions & seizures (139) 139
aged, 80 and over (137) 137
risk factors (136) 136
add-on therapy (135) 135
status epilepticus - drug therapy (135) 135
prospective studies (134) 134
trial (131) 131
refractory epilepsy (130) 130
complications and side effects (127) 127
follow-up studies (127) 127
placebo-controlled trial (126) 126
eeg (125) 125
profile (124) 124
surgery (124) 124
intravenous levetiracetam (121) 121
adults (116) 116
temporal-lobe epilepsy (116) 116
ucb l059 (116) 116
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3220) 3220
Italian (109) 109
Spanish (64) 64
German (48) 48
Russian (46) 46
French (23) 23
Turkish (10) 10
Japanese (9) 9
Hungarian (5) 5
Korean (3) 3
Czech (2) 2
Bosnian (1) 1
Chinese (1) 1
Croatian (1) 1
Danish (1) 1
Persian (1) 1
Polish (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain Injury, ISSN 0269-9052, 2016, Volume 30, Issue 5-6, pp. 682 - 683
Journal Article
International journal of pharmaceutical compounding, ISSN 1092-4221, 03/2017, Volume 21, Issue 2, pp. 127 - 130
Three-dimensional printing quickly became a standard tool in the automotive, aerospace, and consumer goods industries and, recently, has begun gaining traction... 
Journal Article
Clinical Neurophysiology, ISSN 1388-2457, 05/2018, Volume 129, pp. e143 - e143
Ictal tachycardia has been frequently observed during temporal lobe seizures. However, Ictal severe bradycardia and asystole are less common and can be... 
Fainting | Seizures (Medicine) | Epilepsy | Levetiracetam
Journal Article
Clinical Neurophysiology, ISSN 1388-2457, 05/2018, Volume 129, pp. e168 - e168
EPTS occur within seven days of the head trauma. Seizures occur in 10% of traumatic brain injury patients. 20% of people with CHT and intracranial bleeding... 
Brain | Seizures (Medicine) | Injuries | Levetiracetam
Journal Article
The Journal of Maternal-Fetal & Neonatal Medicine, ISSN 1476-7058, 12/2019, Volume 32, Issue 24, pp. 4093 - 4096
Objective: To evaluate levetiracetam (LEV) efficacy in preterm infants admitted in NICU. Study design: Clinical characteristics of 26 preterm infants treated... 
neonatal intensive care | premature | Levetiracetam
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 08/2018, Volume 121, pp. 29 - 33
Selective receptors imaging using gamma emitting radiopharmaceuticals allows accurate diagnosis and follow up of many brain related disorders. Levetiracetam, a... 
Receptor imaging | Radiopharmaceuticals | Microemulsion | Levetiracetam
Journal Article
Turkiye Klinikleri Pediatri, ISSN 1300-0381, 2019, Volume 28, Issue 1, pp. 51 - 54
Journal Article
Netherlands Journal of Critical Care, ISSN 1569-3511, 2015, Volume 20, Issue 2, pp. 29 - 32
Journal Article
Epilepsy & Behavior, ISSN 1525-5050, 01/2018, Volume 78, pp. 194 - 201
Brivaracetam is a new antiepileptic drug indicated for adjunctive treatment of focal seizures in adults at a dose of 50–200 mg/day taken in two equal doses.... 
Antiepileptic drug | Alprazolam | Subjective measures | Brivaracetam | Abuse potential | Levetiracetam | SAFETY | PSYCHIATRY | CLINICAL NEUROLOGY | PARTIAL-ONSET SEIZURES | LIABILITY ASSESSMENT | CNS PHARMACODYNAMICS | PHARMACOKINETICS | DOUBLE-BLIND | BEHAVIORAL SCIENCES | PLACEBO-CONTROLLED TRIAL | ADJUNCTIVE BRIVARACETAM | ADVERSE EVENT PROFILE | Hypnotics and Sedatives - adverse effects | Central Nervous System Depressants - adverse effects | Humans | Middle Aged | Hypnotics and Sedatives - administration & dosage | Anticonvulsants - administration & dosage | Male | Anticonvulsants - pharmacology | Levetiracetam - adverse effects | Central Nervous System Depressants - pharmacology | Pyrrolidinones - administration & dosage | Young Adult | Anticonvulsants - adverse effects | Alprazolam - administration & dosage | Drug-Related Side Effects and Adverse Reactions | Pyrrolidinones - pharmacology | Adult | Female | Alprazolam - pharmacology | Pyrrolidinones - adverse effects | Double-Blind Method | Alprazolam - adverse effects | Levetiracetam - administration & dosage | Street Drugs - adverse effects | Cross-Over Studies | Euphoria | Adolescent | Central Nervous System Depressants - administration & dosage | Levetiracetam - pharmacology | Hypnotics and Sedatives - pharmacology | Drug abuse | Anticonvulsants | Seizures (Medicine) | Analysis | Central nervous system
Journal Article
Pharmacotherapy, ISSN 0277-0008, 11/2001, Volume 21, Issue 11, pp. 1375 - 1388
Levetiracetam is a new antiepileptic drug, structurally and mechanistically dissimilar to other marketed antiepileptic drugs. It is effective in reducing... 
levetiracetam
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.